Science news articles about 'selective estrogen receptor modulator'

... breast cancer by 44 percent, compared with women not taking the drug. Raloxifene is a selective estrogen receptor modulator (SERM), which might suggest that the drug would have a preferential effect ...

... side effects.” Arici said that conservative treatment options include a medical approach using selective estrogen receptor modulators and selective progesterone receptor modulators, uterine artery ...

... history of breast and ovarian cancer is associated with higher risk. Tamoxifen, a selective estrogen receptor modulator (SERM), was approved by the Food and Drug Administration in 1998 to reduce ...

The right combination of estrogen and a selective estrogen receptor modulator (SERM), which blocks the effects of estrogen in breast tissue, could relieve menopause symptoms and cut breast cancer risk ...